|
Name |
secoemestrin D
|
| Molecular Formula | C27H24N2O8S4 | |
| IUPAC Name* |
[12-[(4-hydroxyphenyl)methyl]-18-methyl-11,17-dioxo-5-oxa-13,14,15,16-tetrathia-10,18-diazatetracyclo[10.4.2.01,10.03,9]octadeca-3,6-dien-8-yl]3-hydroxy-4-methoxybenzoate
|
|
| SMILES |
COc1ccc(C(=O)OC2C=COC=C3CC45SSSSC(Cc6ccc(O)cc6)(C(=O)N4C32)N(C)C5=O)cc1O
|
|
| InChI |
InChI=1S/C27H24N2O8S4/c1-28-24(33)27-13-17-14-36-10-9-21(37-23(32)16-5-8-20(35-2)19(31)11-16)22(17)29(27)25(34)26(28,38-40-41-39-27)12-15-3-6-18(30)7-4-15/h3-11,14,21-22,30-31H,12-13H2,1-2H3/t21-,22-,26+,27+/m0/s1
|
|
| InChIKey |
ONXASDRNDFVLMR-DOQQYFFYSA-N
|
|
| Synonyms |
NA
|
|
| CAS | NA | |
| PubChem CID | NA | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 632.76 | ALogp: | 4.5 |
| HBD: | 2 | HBA: | 12 |
| Rotatable Bonds: | 5 | Lipinski's rule of five: | Rejected |
| Polar Surface Area: | 125.8 | Aromatic Rings: | 7 |
| Heavy Atoms: | 41 | QED Weighted: | 0.342 |
| Caco-2 Permeability: | -5.346 | MDCK Permeability: | 0.00001570 |
| Pgp-inhibitor: | 0 | Pgp-substrate: | 0 |
| Human Intestinal Absorption (HIA): | 0.773 | 20% Bioavailability (F20%): | 0.987 |
| 30% Bioavailability (F30%): | 0.995 |
| Blood-Brain-Barrier Penetration (BBB): | 0.729 | Plasma Protein Binding (PPB): | 91.23% |
| Volume Distribution (VD): | 0.787 | Fu: | 21.28% |
| CYP1A2-inhibitor: | 0.152 | CYP1A2-substrate: | 0.119 |
| CYP2C19-inhibitor: | 0.99 | CYP2C19-substrate: | 0.743 |
| CYP2C9-inhibitor: | 0.972 | CYP2C9-substrate: | 0.87 |
| CYP2D6-inhibitor: | 0.758 | CYP2D6-substrate: | 0.107 |
| CYP3A4-inhibitor: | 0.968 | CYP3A4-substrate: | 0.973 |
| Clearance (CL): | 8.576 | Half-life (T1/2): | 0.12 |
| hERG Blockers: | 0.127 | Human Hepatotoxicity (H-HT): | 0.094 |
| Drug-inuced Liver Injury (DILI): | 0.941 | AMES Toxicity: | 0.014 |
| Rat Oral Acute Toxicity: | 0.921 | Maximum Recommended Daily Dose: | 0.917 |
| Skin Sensitization: | 0.339 | Carcinogencity: | 0.98 |
| Eye Corrosion: | 0.003 | Eye Irritation: | 0.005 |
| Respiratory Toxicity: | 0.839 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC002193 | ![]() |
0.367 | D0Q9ON | ![]() |
0.266 | ||
| ENC005414 | ![]() |
0.326 | D07MGA | ![]() |
0.255 | ||
| ENC003597 | ![]() |
0.320 | D01XBA | ![]() |
0.250 | ||
| ENC000134 | ![]() |
0.318 | D05DVP | ![]() |
0.247 | ||
| ENC002571 | ![]() |
0.315 | D0S5RZ | ![]() |
0.245 | ||
| ENC003721 | ![]() |
0.313 | D0JC9N | ![]() |
0.241 | ||
| ENC002587 | ![]() |
0.311 | D0L0SW | ![]() |
0.241 | ||
| ENC003498 | ![]() |
0.310 | D0JY8T | ![]() |
0.239 | ||
| ENC002376 | ![]() |
0.310 | D0VU8Q | ![]() |
0.238 | ||
| ENC002900 | ![]() |
0.308 | D06HBQ | ![]() |
0.237 | ||